.png){kind=icon}
返回
The NIH Somatic Cell Genome Editing program
.png){kind=icon}
OA
AI
DOI：10.1038/s41586-021-03191-1.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
The move from reading to writing the human genome offers new opportunities to improve human health. The United States National Institutes of Health (NIH) Somatic Cell Genome Editing (SCGE) Consortium aims to accelerate the development of safer and more-effective methods to edit the genomes of disease-relevant somatic cells in patients, even in tissues that are difficult to reach. Here we discuss the consortium’s plans to develop and benchmark approaches to induce and measure genome modifications, and to define downstream functional consequences of genome editing within human cells. Central to this effort is a rigorous and innovative approach that requires validation of the technology through third-party testing in small and large animals. New genome editors, delivery technologies and methods for tracking edited cells in vivo, as well as newly developed animal models and human biological systems, will be assembled—along with validated datasets—into an SCGE Toolkit, which will be disseminated widely to the biomedical research community. We visualize this toolkit—and the knowledge generated by its applications—as a means to accelerate the clinical development of new therapies for a wide range of conditions. This Perspective discusses how the Somatic Cell Genome Editing Consortium aims to accelerate the implementation of safe and effective genome-editing therapies in the clinic.
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
48.5
论文数:
3.4W
被引数:
98.1W
机构
查看更多机构
引用论文
Highly efficient endogenous human gene correction using designed zinc-finger nucleases.png)
Nature
NatureIF0
PREAI
分享收藏
Development and application of human skeletal muscle microphysiological systemsLAB ON A CHIPOAAI
LAB ON A CHIPIF5.4
OAAI分享收藏A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome EditingCRISPR/Cas9脂质纳米颗粒的单次给药实现了强大而持久的体内基因组编辑CELL REPORTSOAAI
CELL REPORTSIF6.9
OAAI分享收藏CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells用于诱导人类细胞中靶向DNA颠转的CRISPR c--g碱基编辑器NATURE BIOTECHNOLOGYOAAI
NATURE BIOTECHNOLOGYIF41.7
OAAI分享收藏A TALE nuclease architecture for efficient genome editing用于高效基因组编辑的TALE核酸酶架构NATURE BIOTECHNOLOGY
NATURE BIOTECHNOLOGYIF41.7
PREAI
分享收藏The NextGen Genetic Association Studies Consortium: A Foray into In Vitro Population GeneticsCELL STEM CELLOAAI
CELL STEM CELLIF20.4
OAAI分享收藏分享收藏In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle deliveryNATURE COMMUNICATIONSOAAI
NATURE COMMUNICATIONSIF15.7
OAAI分享收藏 查看更多内容